Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1745studies shown
Showing 1,153-1,164 of 1,745
Drug study icon
CompletedNCT06653296

A Dose-Response Safety Study of ENX-102 in people with GAD

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
AnxietyDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Engrail Therapeutics INC
Condition
Anxiety
Drug study icon
CompletedEUCTR 2018-002782-19

CARIPRAZINE for depression

This study is completed in the United Kingdom, in Germany, in Hungary, .... It is testing CARIPRAZINE for depression.

In United Kingdom
DepressionOther
Countries
United Kingdom, Germany, Hungary, ...
Sponsor
Allergan Ltd.
Condition
Depression
Drug study icon
CompletedEUCTR 2014-005206-37

Sirukumab for depression

This study is completed in the United Kingdom and in Poland. It is testing sirukumab for depression.

In United Kingdom
DepressionOther
Countries
United Kingdom, Poland
Sponsor
Janssen-Cilag International N.V.
Condition
Depression
Drug study icon
OngoingEUCTR 2017-002227-13

Pimavanserin for Schizophrenia

This study is ongoing in France, in the United Kingdom, in Czechia, .... It is testing pimavanserin for Schizophrenia.

In United Kingdom
SchizophreniaOther
Countries
France, United Kingdom, Czechia, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedEUCTR 2013-000212-22

GWP42003 for schizophrenia

This study is completed in the United Kingdom, in Poland, and in Romania. It is testing GWP42003 for schizophrenia.

In United Kingdom
SchizophreniaOther
Countries
United Kingdom, Poland, Romania
Sponsor
GW Research Ltd
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2020-000341-14

Seltorexant 20 mg for Depression

This study is completed in the United Kingdom, in Belgium, in Czechia, .... It is testing Seltorexant 20 mg for Depression.

In United Kingdom
DepressionOther
Countries
United Kingdom, Belgium, Czechia, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.